Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |